Midatech Pharma Plc

Midatech Pharma (MTPH)

Company name:Midatech Pharma Plc
EPIC:MTPHTrading Currency:GBX
Market Sector:AMQ1ISIN:GB00BKT14T00
Market Segment:ASQ1Share Type:DE
WWW Address:http://midatechgroup.com/investorsDescription:ORD 0.1P
 Price Price Change [%] Bid Offer Open High Low Volume
 26.00 images.advfn.com/imagesnew/2/gb/down -0.5 [-1.89] 25.00 27.00 26.50 26.50 26.00 30,685
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 25.60 98.47 0.26 -50.00 - - - 52.75 - 23.00

Midatech Pharma Key Figures

(at previous day's close)
Market Cap.25.60m
Shares In Issue98.47m
Prev. Close26.50
PE Ratio- 
Dividend Yield-%
EPS - basic-50.00p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-6.59p
Return On Equity (ROE)-51.56%
Operating Margin-3,500.96%
PEG Factor- 
EPS Growth Rate-300.00%
Dividends PS Growth Rate-%
Net Debt0.41m
Gross Gearing36.70%
Quick Assets16.36m
Net Working Capital10.70m
Intangibles / Fixed Assets85.18%
Turnover PS0.32p
Pre-Tax Profit PS-11.09p
Retained Profit PS-10.24p
Cash PS11.10p
Net Cash PS5.34p
Net Tangible Asset Value PS *7.29p
Net Asset Value PS19.86p
Spread2.00 (7.41%) 

Midatech Pharma Balance Sheet


Share Price Performance

Sample Period HighLow
1 week26.5026.00
4 weeks29.0026.00
12 weeks50.5023.00
1 year52.7523.00

Share Price Chart (5 years)

Midatech Pharma Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week26.25-0.25-0.9526.000.1026.50
4 weeks29.00-3.00-10.3426.000.2027.37
12 weeks27.50-1.50-5.4523.000.6533.09
26 weeks39.00-13.00-33.3323.000.4133.93
1 year31.00-5.00-16.1323.000.4934.45
3 years260.00-234.00-90.001.900.7755.32
5 years1,125.00-1,099.00-97.691.900.4984.30

Midatech Pharma Key Management Ratios

Midatech Pharma Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 1.00 
Tobin's Q Ratio (excl. intangibles)1.93 
Dividend Yield-%
Market-to-Book Ratio1.31 
Price-to-Pre-Tax Profit PS-2.34 
Price-to-Retained Profit PS-2.54 
Price-to-Cash Flow PS-3.95 
Price-to-Sales PS82.06 
Price-to-Net Tangible Asset Value PS3.57 
Price-to-Cash PS2.34 
Net Working Capital PS10.86 
Price Pct to Working Capital PS2.39%
Earnings Yield-%
Average PE2.40 
Years in average1 
PE to PE average-%

Midatech Pharma Financial Ratios

(Leverage Ratios)
Debt Ratio22.48%
Debt-to-Equity Ratio0.29 
Debt-to-Equity Ratio (excl. Intgbl)0.79 
Debt-to-Equity Market Value0.22 
Net Gearing1.32%
Net Gearing (excl. Intangibles)2.21%
Gross Gearing36.70%
Gross Gearing (excl. Intangibles)61.23%
Gearing Under 1 Year18.34%
Gearing Under 1 Year (excl. Intgbl)30.61%
(Liquidity Ratios)
Net Working Capital to Total Assets34.62%
Current Ratio2.89 
Quick Ratio (Acid Test)2.89 
Liquidity Ratio1.93 
Cash & Equiv/Current Assets66.79%
(Solvency Ratios)
Enterprise Value20.34m
CFO/Attributable Profit- 
Total Debt/Equity Market Value0.44 
Total Debt/Sales36.34 
Total Debt/Pre-Tax Profit-1.04 
Total Debt11.34m
Total Debt/Net Current Assets1.06%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs2 
Beta (60-Mnth)Beta (36-Mnth)

Midatech Pharma Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-43.30%
Return On Assets (ROA)-39.29%
Net Profit Margin-3,232.37%
Assets Turnover0.01 
Return On Equity (ROE)-51.56%
Return On Investment (ROI)-46.69%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-3,232.37%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.02 
Fixed Assets Turnover0.02 
Current Assets Turnover0.03 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales82.27 
Debt Collection Period5,368.54Days

Midatech Pharma Dividends

Sorry No Data Available

Midatech Pharma Fundamentals

 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
pre tax profit-29.32-423.54%-17.33-256.42%-12.40--10.92-m
attributable profit-20.16-291.23%-16.06-237.70%-15.03--10.09-m
retained profit-20.16-291.23%-16.06-237.70%-15.03--10.09-m
eps - basic (p)-56.00 -31.00 25.00 -50.00 
eps - diluted (p)-56.00 -31.00 25.00 -50.00 
dividends per share- - - - 

Midatech Pharma Balance Sheet

 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
fixed assets fixed assets2.774.88%2.535.14%1.989.70%2.156.97%m
intangibles intangibles31.1754.99%27.6556.17%12.3760.53%12.3840.07%m
fixed investments fixed investments--%--%--%--%m
current assets - other current assets - other--%--%--%--%m
stocks stocks0.821.44%0.941.91%--%--%m
debtors debtors4.337.63%4.909.96%3.7418.31%5.4317.59%m
cash & securities cash & securities17.6131.06%13.2026.82%2.3411.46%10.9335.37%m
creditors - short creditors - short9.3516.48%8.3616.99%2.4712.09%5.6718.34%m
creditors - long creditors - long1.622.86%6.1912.57%1.055.13%5.6718.35%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves45.7280.66%34.6870.45%16.9282.78%19.5663.30%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Midatech Pharma Cash Flow Statement

31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
Operating CF-13.09-12.95-13.45-6.49m
Pre-Financing CF-14.29-14.42-4.41-10.30m
Retained CF0.97-4.15-10.888.44m

Midatech Pharma Brokers

Broker infomation is not available for this class of stock.
ADVFN Advertorial
Your Recent History
Midatech P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210805 11:57:28